Chien-Ching Li to Neoadjuvant Therapy
This is a "connection" page, showing publications Chien-Ching Li has written about Neoadjuvant Therapy.
Connection Strength
0.541
-
The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy. Tumour Biol. 2015 Sep; 36(10):7675-83.
Score: 0.130
-
Overexpression of DNAJC12 predicts poor response to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer. Exp Mol Pathol. 2015 Jun; 98(3):338-45.
Score: 0.129
-
PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy. Histopathology. 2015 Jun; 66(7):991-1002.
Score: 0.127
-
Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy. J Clin Pathol. 2014 Dec; 67(12):1056-61.
Score: 0.125
-
Overexpression of CPS1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy. Tumour Biol. 2014 Nov; 35(11):11097-105.
Score: 0.031